The DOI matches its Crossref record.
Soluble membrane‐type 1 matrix metalloproteinase (MT1‐MMP) and gelatinase A (MMP‐2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis
Abstract
The aim of this study was to investigate the involvement of the MT1‐MMP/MMP‐2 cascade in induced sputum (IS) and bronchoalveolar lavage fluid (BALF) from bronchial asthma (BA) and bronchiectasis (BE) patients and healthy controls. The molecular forms and cellular origins of MT1‐MMP and MMP‐2 were determined by Western immunoblotting, immunohistochemistry and in situ hybridization. Elevated levels of soluble activated and autocatalyzed MT1‐MMP species as well as activated forms of MMP‐2 in IS and BALF samples from BA and BE patients were evidenced. The activation degrees of soluble MT1‐MMP and MMP‐2 were significantly correlated in BA and BE IS and BALF. Only low levels of both these MMPs were observed in healthy control IS and BALF. The co‐expression of MMP‐2 with MT1‐MMP was evidenced by double immunostaining in bronchial epithelial cells, submucosal glandular cells, smooth muscle cells and monocyte/macrophages. The MT1‐MMP/MMP‐2 cascade is present and active in human inflammatory lung disease fluid and tissue samples. This cascade seemingly reflects the active destructive phases of these chronic lung diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MT1-MMP is constitutively shed via proteolytic cleavage by ADAM family metalloproteinases, resulting in detectable quantities of soluble MT1-MMP (sMT1-MMP) in the plasma.
“MT1-MMP is constitutively shed via proteolytic cleavage by A Disintegrin and Metalloproteinase (ADAM) family metalloproteinases, resulting in detectable quantities of soluble MT1-MMP (sMT1-MMP) in the plasma20–22.”
From MT1-MMP inhibition rejuvenates ageing brain and rescues cognitive deficits in obesity (2025) · cites this paper as [21]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 44
- 10.1016/S0955-0674(98)80035-5 · DOI
- 10.1136/thx.49.6.602 · DOI
- 10.1378/chest.107.6.1641 · DOI
- 10.1183/09031936.97.10122788 · DOI
- 10.1111/j.1699-0463.1999.tb01536.x · DOI
- 10.1074/jbc.274.13.8925 · DOI
- 10.1074/jbc.271.15.9135 · DOI
- 10.1111/j.1432-1033.1997.00751.x · DOI
- 10.1074/jbc.272.4.2446 · DOI · Paper page
- Ohnishi K, 1998, Matrix metalloproteinase‐mediated extracellular matrix protein degradation in human pulmonary emphysema, Lab Invest, 78, 1077
- 10.1046/j.1523-1755.1998.00216.x · DOI
- 10.1002/(SICI)1098-2744(199806)22:2<84::AID-MC3>3.0.CO;2-K · DOI
- Imai K, 1996, Membrane‐type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2, Cancer Res, 56, 2707
- 10.1074/jbc.270.10.5331 · DOI
- 10.1164/ajrccm/136.1.225 · DOI
- 10.1136/thx.52.6.498 · DOI
- 10.1074/jbc.272.34.21067 · DOI
- 10.1111/j.1749-6632.1999.tb07679.x · DOI
- 10.1002/path.849 · DOI
- 10.1016/S0021-9258(19)38559-X · DOI
- 10.1378/chest.106.4.1129 · DOI
- 10.1165/ajrcmb.17.5.2562 · DOI
- 10.3109/07853890108995957 · DOI
- 10.1164/ajrccm.158.6.9803014 · DOI
- Lemjabbar H, 1999, Am J Respir Crit Care, Med, 159, 1298
- 10.1067/mai.2000.105316 · DOI
- 10.1016/S0091-6749(99)70379-9 · DOI
- 10.1074/jbc.275.16.12080 · DOI
- 10.1038/370061a0 · DOI
- 10.1074/jbc.270.10.5331 · DOI
- 10.1074/jbc.270.51.30479 · DOI
- 10.1111/j.1432-1033.1996.0239u.x · DOI
- 10.1242/jcs.111.18.2789 · DOI
- 10.1074/jbc.271.41.25548 · DOI
- Fukuda Y, 1998, Localization of matrix metalloproteinases‐1, ‐2, and ‐9 and tissue inhibitor of metalloproteinase‐2 in interstitial lung diseases, Lab Invest, 78, 687
- 10.1016/S0002-9440(10)65625-8 · DOI
- 10.7326/0003-4819-123-4-199508150-00008 · DOI
- Sommerhoff CP, 1996, Classical second messengers are not involved in proteinase‐induced degranulation of airway gland cells, Am J Physiol, 271, L796
- 10.3109/01902149709074028 · DOI
- 10.1042/bj2880093 · DOI
- 10.1152/ajplung.1999.277.6.L1109 · DOI
- 10.1074/jbc.270.11.5872 · DOI
- 10.1016/S0945-053X(98)90110-X · DOI
- 10.2174/0929867013373660 · DOI
Cited by
Sorted by citations
MT1-MMP inhibition rejuvenates ageing brain and rescues cognitive deficits in obesity
Asthana, P., Li, L., Lu, L., Wu, J., Zhang, S., Li, N., Wong, S. K. K., Gurung, S., Zhang, Y., Lin, Y., et al. (2025) · Cell Discovery · doi:10.1038/s41421-025-00825-w · Cited by 4
Metadata
- Authors
- MAISI, P., PRIKK, K., SEPPER, R., PIRILÄ, E., SALO, T., HIETANEN, J., & SORSA, T.
- Venue
- APMIS
- Publisher
- Wiley
- Published
- 2002-11
- Volume
- 110
- Issue
- 11
- Pages
- 771-782
- ISSN
- 0903-4641
- 1600-0463
- Cited by
- 52
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review